Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia

T. Matsui, N. Inui, T. Fujisawa, N. Enomoto, T. Suda, K. Chida, Y. Miyamoto, N. Takai (Hamamatsu, Japan)

Source: Annual Congress 2006 - Clinical features of interstitial lung disease
Session: Clinical features of interstitial lung disease
Session type: Electronic Poster Discussion
Number: 1776
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Matsui, N. Inui, T. Fujisawa, N. Enomoto, T. Suda, K. Chida, Y. Miyamoto, N. Takai (Hamamatsu, Japan). Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia. Eur Respir J 2006; 28: Suppl. 50, 1776

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies.
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018




Anti-endothelial cell antibodies in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 56s
Year: 2007

Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012


Anti-parietal cell autoimmunity in IPF patients
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006

Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype
Source: Eur Respir J, 56 (6) 2001205; 10.1183/13993003.01205-2020
Year: 2020



Distinctive polarization of circulating classical monocytes between idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)
Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017
Year: 2018



Evaluation of interstitial inflammatory cell in idiopathic interstitial pneumonias
Source: Eur Respir J 2006; 28: Suppl. 50, 99s
Year: 2006

Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002



Clinico-radiological-pathological features of MPO-ANCA-positive interstitial pneumonia
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
Source: Eur Respir Rev 2015; 24: 370-372
Year: 2015


Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Characterisation of patients with interstitial pneumonia with autoimmune features
Source: Eur Respir J 2016; 47:1767-1775
Year: 2016



The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008



Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Autoantibodies in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Source: Eur Respir J, 56 (4) 2000117; 10.1183/13993003.00117-2020
Year: 2020



Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002